Drug Profile
Ondansetron oral dispersible film - Aquestive Therapeutics
Alternative Names: Ondansetron ODF; Ondansetron ODFS; Ondansetron oral soluble film; Thin film ondansetron; ZuplenzLatest Information Update: 07 Apr 2023
Price :
$50
*
At a glance
- Originator MonoSol Rx LLC
- Developer Aquestive Therapeutics
- Class Anti-inflammatories; Antiemetics; Antipsychotics; Carbazoles; Drug withdrawal therapies; Imidazoles; Irritable bowel syndrome therapies; Obesity therapies; Small molecules; Smoking cessation therapies
- Mechanism of Action Serotonin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Marketed Chemotherapy-induced nausea and vomiting; Postoperative nausea and vomiting; Radiotherapy-induced nausea and vomiting